Who, What, Where, When (and Maybe Even Why)? How the Experience of Sexual Reward Connects Sexual Desire,Preference, and Performance
Arch Sex Behav - 2012 : Mar 9. [Epub ahead of print]
Spontaneous contractile activity of human neurogenic bladder strips: Can we predict a correlation with between clinical factors, urodynamics and histological features ?
27 th Congress of the European Association of Urology, February 2012, Paris, France.
European Urology Supplements - 2012 : 11; e472
Minimal Effective Dose of Dysport and Botox in a Rat Model of Neurogenic Detrusor Overactivity
Eur Urol - 2012 : 61(5):1054-61
Vardenafil decreases bladder afferent nerve activity in unanesthetized, decerebrate, spinal cord-injured rats.
Eur Urol - 2011 : 59(2):272-279
Combination of BAY 60-4552 and vardenafil exerts proerectile facilitator effects in rats with cavernous nerve injury: A proof of concept study for the treatment of PDE5 inhibitor failure
Eur. Urol. - 2011 : 60(5):1020-1026
Botulinum neurotoxin A for male lower urinary tract symptoms.
Curr Opin Urol. - 2011 : Jan;21(1):13-21. Erratum in: Curr Opin Urol. 2011 May;21(3):265. Dosage error in article text.
Phosphodiesterase type 5 inhibitors in the management of non-neurogenic male lower urinary tract symptoms: critical analysis of current evidence.
Eur Urol. - 2011 : Sep ; 60(3):527-35.
Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia.
Eur Urol. - 2011 : Oct ; 60(4):809-25.
Neurophysiology of erection and ejaculation.
J Sex Med. - 2011 : Oct 8 ; Suppl 4:310-5.
Experimental evidence that a combination of sGC stimulator BAY 60-4552 and PDE5 inhibitor vardenafil might salvage patients with insufficient response to PDE5 inhibitors after cavernous nerve injury
American Urological Association Annual Meeting 14 -19 may 2011, Washington, DC, USA.
J. Urol - 2011 : 185, 4, Suppl 1, p.e305-e306
A new experimental rat model of erectile dysfunction and lower urinary tract symptoms associated with benign prostate hyperplasia : the testosterone-supplemented spontaneously hypertensive rat
American Urological Association Annual Meeting 14 -19 may 2011, Washington, DC, USA.
J. Urol - 2011 : 185, 4, Suppl 1, p.e631
Effects of potassium channel modulators on myogenic spontaneous phasic contractile activity in human detrusor from neurogenic patients
BJU Int - 2011 : 108(4):604-11
Experimental evidence that a combination of sGC stimulator BAY 60-4552 and PDE5 inhibitor vardenafil might salvage patients with insufficient response to PDE5 inhibitors after cavernous nerve injury
26 th Congress of the European Association of Urology, March 2011, Vienna
European Urology Supplements - 2011 : 10(2), p 331
Experimental Models for the Study of Female and Male Sexual Function.
J. Sex. Med. - 2010 : 7(9):2970-2995
Experimental Models for the Study of Female and Male Sexual Function
J Sex Med - 2010 : 7(9):2970-2995
Baseline characteristics of women enrolled in a prospective study of surgical clitoral repair after genital mutilation
9the annual meeting of nternational Society for the Study of Women’s Sexual Health (ISSWSH), 18-21 February 2010, St Petersburg, Florida, USA
J. Sex. Med. - 2010 : Vol. 7, s3, #23, page 142
A new experimental rat model of erectile dysfunction and lower urinary tract symptoms associated with benign prostate hyperplasia : the testosterone supplemented spontaneously hypertensive rat
13th congress of the European Society for Sexual Medicine (ESSM) Nov 14-17 Malaga, Spain
J. Sex. Med. - 2010 : 7(s6)
Neuroanatomical distribution of the melanocortin-4 receptors in male and female rodent brain
Journal of Chemical Neuroanatomy - 2010 : 40:310-324
Effects of flibanserin on appetitive and consummatory aspects of sexual behavior in ovariectomized female rats primed with estrogen and progesterone
International Society for Sexual Medicine (ISSM), 14th World Meeting in Seoul, South Korea, 26 - 30 September 2010.
J Sex Med - 2010 : 7 (suppl 4):151